News Search Results
Jul 01, 2024, 20:00 ET Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced oral presentation of the latest Phase 1 clinical data of an innovative anti-CLDN18.2 ADC (IBI343) for the treatment
More news about: Innovent Biologics
Jul 01, 2024, 07:57 ET Orbis International Brings Sight-Saving Glaucoma Training to Rural Peru
Held at the Regional Institute of Ophthalmology (IRO), the leading specialized eye hospital in the rural La Libertad region of northern Peru, the training will
More news about: Orbis International
Jun 27, 2024, 20:00 ET Innovent Provides Interpretation and Updates on Clinical Data from Mazdutide GLORY-1 Study and General Biomedicine Pipeline
Sjögren's syndrome, systemic lupus erythematosus, atopic dermatitis, asthma, and other diseases. Ophthalmology: advancing treatment standards In the field of ophthalmology, Innovent's new drug application for IBI311 Injection (recombinant anti-insulin-like growth factor 1 receptor
More news about: Innovent Biologics
Jun 27, 2024, 08:11 ET Lindus Health Launches Bespoke "All-in-One Medical Device CRO" Offering for Medical Device Clinical Trials
Europe, and has demonstrated consistent success in executing device studies across virtually all therapeutic areas, including neurology, ophthalmology, cardiovascular, respiratory, and more. This covers many device types including Class I (low-risk) and Class II (moderate-risk) devices, diagnostics
More news about: Lindus Health
Jun 26, 2024, 09:00 ET ZEISS arivis software enhances custom microscopy image analysis
assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture
More news about: ZEISS Research Microscopy Solutions
Jun 25, 2024, 11:00 ET American Board of Medical Specialties Research and Education Foundation Announces Recipients of Inaugural Research Grants
Decisions and Resident-Driven Learning"Fasika Woreta, MD, MPH, Associate Professor of Ophthalmology, Wilmer Eye Institute/Johns Hopkins University School of Medicine - Gender, Racial and Ethnic Diversity in Oral Board
More news about: American Board of Medical Specialties
Jun 25, 2024, 11:00 ET NORTHSTAR ANESTHESIA AND EYESOUTH PARTNERS EXPAND PARTNERSHIP TO EYE CARE CENTERS IN CINCINNATI, CHICAGO, AND ATLANTA
2024 /PRNewswire/ -- NorthStar Anesthesia, an industry leader in anesthesia care, and EyeSouth Partners, the largest surgically-focused ophthalmology managed service organization in the country, have expanded their partnership to pair NorthStar's anesthesia services with five additional EyeSouth
More news about: NorthStar Anesthesia
Jun 25, 2024, 10:01 ET Research Antibodies and Reagents Market to be Worth $6.77 Billion by 2031 - Exclusive Report by Meticulous Research®
DiseasesCardiologyImmunologyNeurologyStem Cell ResearchOther Research Areas(Other Research Areas include Ophthalmology and Rare diseases) ReagentSample Preparation ReagentsMedia and SerumStains
More news about: Meticulous Market Research Pvt. Ltd.
Jun 25, 2024, 08:33 ET US Eye Partners with WhiteSpace Health for Analytics Platform
EyeUS Eye is a leading group of patient-centric, vertically integrated multi-specialty physician practices providing patients with care in ophthalmology, optometry, dermatology, and cosmetic facial surgery. US Eye is based in University Park, Florida, employing over
More news about: WhiteSpace Health
Jun 24, 2024, 20:14 ET Innovent Presents the Results of the First Phase 3 Study of Mazdutide for Weight Management at the ADA's 84th Scientific Sessions
that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, presents the key results of the first Phase 3 clinical trial of mazdutide in Chinese adults with overweight or obesity
More news about: Innovent Biologics
Jun 24, 2024, 20:00 ET Innovent Announces Mazdutide Demonstrates 80.2% Reduction in Liver Fat Content in Exploratory Analysis of Phase 3 Weight Management GLORY-1 Study at ADA 2024
that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, reports the results of liver fat content from the Phase 3 study of mazdutide in Chinese adults with overweight or obesity
More news about: Innovent Biologics
Jun 24, 2024, 17:52 ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Skye Bioscience, Inc. - SKYE
("IOP"). Skye intends to discontinue clinical development and spending related to SBI-100 OE and any R&D associated with SBI-100, including its ophthalmology pipeline, and direct all clinical development resources to its metabolic program, extending its operating runway into 2027." On this news,
More news about: Pomerantz LLP
Jun 24, 2024, 10:00 ET RevOpsis Appoints Ronil Patel as Chief Business Officer
currently serves as a strategic advisor to Collage Venture Partners and was previously the Chief Business Officer at Ocuphire Pharma, a publicly traded ophthalmology biotechnology company. Prior to Ocuphire, Patel led business development for Point Guard Partners and Oculos Clinical Research (now iuvo Bioscience).
More news about: RevOpsis
Jun 24, 2024, 07:50 ET Sun Pharma Completes Taro Merger
company in the US as well as Global Emerging Markets. Sun Pharma's high growth Global Specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharma
Jun 24, 2024, 07:47 ET Sun Pharma Completes Taro Merger
company in the US as well as Global Emerging Markets. Sun Pharma's high growth Global Specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharma
Jun 22, 2024, 08:03 ET Sun Pharma's GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions
generic company in the US as well as Global Emerging Markets. Sun's high growth Global Specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharmaceutical Industries Limited
Jun 20, 2024, 08:30 ET Ace Vision Group Strengthens Executive Team with Addition of Frank Chen as Chief Operating Officer
laser treatment that aims to restore visual function naturally without sacrificing distance vision. AVG's brand promise is to provide the field of ophthalmology with innovative devices, Microporation Therapeutic procedures, and education for the treatment of age-related ocular dysfunction, disability, and
More news about: Ace Vision
Jun 19, 2024, 17:23 ET Watertown Regional Medical Center Partners with HOPCo To Enhance Orthopedic and Spine Services
services have grown to include Emergency, Primary Care, Women's Health, Orthopedics and Sports Medicine, Heart and Vascular, Neurology, Pulmonology, Ophthalmology, and many other services. Watertown Regional Medical Center is a joint venture between the Greater Watertown Community Health Foundation and ScionHealth.
More news about: Healthcare Outcomes Performance Company
Jun 18, 2024, 22:52 ET Innovent Reports Oncology Pipeline Updates at Investor Meeting
biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, provided updates on its oncology pipeline at an investor meeting. At several major international oncology annual meetings
More news about: Innovent Biologics
Jun 18, 2024, 10:00 ET Bloomage Leads Discussions of Hyaluronic Acid Development at 2nd Hyaluronic Acid Industry Conference
hyaluronic acid is renowned for its exceptional moisturizing properties. However, it also applies in many other fields, including orthopedics, ophthalmology, and nutrition. Dr. Xueping Guo, Chief Scientist of Bloomage, underscored several of hyaluronic acid's
More news about: Bloomage
Jun 18, 2024, 08:00 ET Real-World Data Reinforces Efficacy of Luminopia in Improving Vision for Patients with Amblyopia
for Pediatric Ophthalmology and Strabismus (AAPOS) 2024 annual meeting in April by Euna Koo, MD, Clinical Associate Professor of Ophthalmology, Stanford University and then at the Association for Research in Vision and Ophthalmology (ARVO) 2024
More news about: Luminopia
Jun 17, 2024, 09:03 ET RevOpsis and Kemwell Biopharma Enter into Strategic Manufacturing Partnership to Expedite Development of Novel Multispecific Biologics
the Rev-Mod platform enables swift and efficient design of multispecific biologics to address unmet needs in major therapeutic areas including ophthalmology, oncology, and immune-mediated diseases. About RevOpsis TherapeuticsFounded in 2018, RevOpsis Therapeutics is a privately
More news about: RevOpsis
Jun 14, 2024, 14:55 ET Optometry Software Market Size in North America to grow by USD 576.62 million from 2024-2028, Increasing prevalence of ophthalmic diseases to boost the market growth, Technavio
a CAGR of 6.67% during the forecast period. Increasing prevalence of ophthalmic diseases is driving market growth, with a trend towards growing ophthalmology market. However, rising medical data privacy concerns poses a challenge. Key market players include Barti, Compulink Healthcare Solutions, Doctorsoft
More news about: Technavio
Jun 14, 2024, 06:34 ET Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a Single Injection of MM-II in Patients with Painful Knee Osteoarthritis (OA)
generic company in the US as well as Global Emerging Markets. Sun's high growth Global Specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Moebius
Jun 14, 2024, 05:48 ET Global Cell and Gene Therapy Market Expected to Grow at 26.4% CAGR, Reaching $23.3 Billion by 2028
ApplicationThe cell and gene therapy manufacturing services market serves various applications, including oncology (cancer treatment), rare diseases, ophthalmology (eye-related conditions), and other medical fields. These applications represent the different areas where cell and gene therapies are used to treat
More news about: BCC Research LLC